🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07462247
Recruiting Observational

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

NCT07462247 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Observational
Started
2026-03-11
Last updated
2026-03-12

Condition(s) studied

Upper Gastrointestinal CancerUpper Gastrointestinal Precancerous LesionsUpper Gastrointestinal Precancerous Conditions

Investigational drug(s) / intervention(s)

magnetically-controlled capsule endoscopy, esophagogastroduodenoscopy, CT scanESD, biopsy

magnetically-controlled capsule endoscopy, esophagogastroduodenoscopy, CT scan: Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions

ESD, biopsy: ESD or biopsy for histopathology results

Study summary

The study is designed to collect magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT images, and histopathology results to establish a database for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Male or female participants aged ≥ 18 years 2. Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD) 3. Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent Exclusion Criteria: 1. Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure 2. Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance 3. Suspected or known intestinal stenosis or other known risk factors for capsule retention 4. Patients with dysphagia 5. Pregnancy 6. Allergy to polymeric materials, latex, simethicone, or pronase 7. Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule 8. Patients with any condition that precludes compliance with the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Changhai Hosptial Shanghai China Recruiting

More Changhai Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07462247 on ClinicalTrials.gov ↗ ← All trials in China